Sponsors of COVID-19 treatments may apply for:

• provisional registration through the  provisional approval pathway, which provides an expedited pathway for assessment based on available preliminary data
• full registration through the Prescription Medicines Registration Process, if they possess clinical data to confirm the longer-term safety and efficacy of their medicine.

Australia is working internationally to share research and information supporting new COVID-19 treatments. For more information, visit International collaboration.